➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Boehringer Ingelheim
McKinsey
Medtronic
Baxter

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for clonazepam and what is the scope of freedom to operate?

Clonazepam is the generic ingredient in three branded drugs marketed by Alembic Pharms Ltd, Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Mylan, Mylan Pharms Inc, Prinston Inc, Rubicon, Sandoz, Teva, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Thirty-eight suppliers are listed for this compound.

Drug Prices for clonazepam

See drug prices for clonazepam

Drug Sales Revenue Trends for clonazepam

See drug sales revenues for clonazepam

Recent Clinical Trials for clonazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Queen Sirikit National Institute of Child HealthN/A
University of CincinnatiPhase 4
Ministry of Science and Technology, TaiwanN/A

See all clonazepam clinical trials

Pharmacology for clonazepam
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for clonazepam

US Patents and Regulatory Information for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth CLONAZEPAM clonazepam TABLET;ORAL 074869-003 Oct 31, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 078654-005 Aug 27, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc CLONAZEPAM clonazepam TABLET;ORAL 074940-003 Oct 30, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs CLONAZEPAM clonazepam TABLET;ORAL 074964-002 Dec 30, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare CLONAZEPAM clonazepam TABLET;ORAL 077147-003 May 2, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Actavis Elizabeth CLONAZEPAM clonazepam TABLET;ORAL 074869-002 Oct 31, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN clonazepam TABLET;ORAL 017533-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-004 Dec 23, 1997   Start Trial   Start Trial
Roche KLONOPIN clonazepam TABLET;ORAL 017533-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997   Start Trial   Start Trial
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-003 Dec 23, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.